Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and hyaluronic acid for moderate-to-severe knee osteoarthritis
ChiCTR2100050974Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA) (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Change in WOMAC score at 6 months from baseline. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
platelet-rich plasmahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2100050974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050974.